Establishment of prediction method of malignancy and treatment resistance by fibrotic stroma quantification of pancreatic cancer using iodine map

Establishment of prediction method of malignancy and treatment resistance by fibrotic stroma quantification of pancreatic cancer using iodine map - Establishment of prediction method of malignancy and treatment resistance by fibrotic stroma quantification of pancreatic cancer using iodine map

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036842

Enrollment

200

Registered

2019-05-25

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients whose medical information and prognosis information can be obtained from medical records. Patients with a definite diagnosis of pancreatic cancer. Patients undergoing treatment for pancreatic cancer at our hospital.

Exclusion criteria

Exclusion criteria: Patients who have not been requested to participate in this study from the published information. Patients who are, or will be, participating in a clinical study with drug treatment interventions. Patients who the research representative judged inappropriate.

Design outcomes

Primary

Measure	Time frame
Noninvasively predict malignancy and treatment resistance of pancreatic cancer by quantitatively measuring the degree of fibrotic interstitium in pancreatic cancer using an iodine map obtained from dynamic contrast-enhanced CT imaged by Dual-Energy CT .	—

Countries

Japan

Contacts

Public Contactshigeto ashina

kobe university Gastroenterology

sashina@med.kobe-u.ac.jp078-382-6305

Outcome results